SCHEMBL5659646

SCHEMBL5659646

COC(=O)c1cc(OC)c(OC)c2oc(C(=O)c3ccc(-c4ccccc4)cc3)cc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.47
MEN1 O00255 2/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
KMT2A Q03164 2/20 0.47
POLB P06746 5/20 0.43
MAPT P10636 3/20 0.43
ALDH1A1 P00352 2/20 0.43
HTT P42858 2/20 0.43
LMNA P02545 2/20 0.43
HPGD P15428 1/20 0.43
ATM Q13315 1/20 0.42
TUBB4A P04350 2/20 0.41
TUBB P07437 2/20 0.41
TUBA3C P0DPH7 2/20 0.41
TUBA1B P68363 2/20 0.41
TUBA4A P68366 2/20 0.41
TUBB4B P68371 2/20 0.41
TUBB3 Q13509 2/20 0.41
TUBB2A Q13885 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5659664 0.93 KMT2A (0.54) SMN1; SMN2MEN1NPC1RAB9AKMT2A
SCHEMBL5658511 0.88 MAPT (0.54) SMN1; SMN2MEN1NPC1RAB9AKMT2A
SCHEMBL5668947 0.87 SMN1; SMN2 (0.45) SMN1; SMN2MEN1NPC1RAB9AKMT2A
SCHEMBL5657737 0.83 PDE4B (0.46) SMN1; SMN2MEN1KMT2APOLBALDH1A1
SCHEMBL5661034 0.82 ACHE (0.55) POLBMAPTALDH1A1HTTHPGD
SCHEMBL5669321 0.81 KDM4E (0.49) POLBMAPTALDH1A1HTTLMNA
SCHEMBL6837653 0.79 SMN1; SMN2 (0.60) SMN1; SMN2MEN1NPC1RAB9AKMT2A
SCHEMBL5657720 0.77 KDM4E (0.46) SMN1; SMN2POLBALDH1A1HTTHPGD
SCHEMBL5655755 0.76 KDM4E (0.46) SMN1; SMN2MEN1KMT2APOLBMAPT
SCHEMBL5657180 0.76 KDM4E (0.46) MEN1KMT2APOLBMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7030130-B2 Benzofuran derivatives and their use as antibacterial agents ARPIDA AG (CH) 2006-04-18 US disclosed
EP-1307445-B1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS ARPIDA AG (CH) 2005-12-21 EP disclosed
US-20040034047-A1 Benzofuran derivatives and their use as antibacterial agents EVOLVA SA (CH) 2004-02-19 US disclosed
EP-1307445-A1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS Arpida AG, (CH) 2003-05-07 EP disclosed
WO-2002010157-A1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS ARPIDA AG (CH) 2002-02-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040034047-A1 Benzofuran derivatives and their use as antibacterial agents SBDS, BPTF, DCXR SMN1; SMN2 3686/4885MEN1 4413/4885NPC1 2360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.